Pseudoneoplastic lesions of the female genital tract.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Archives of pathology & laboratory medicine (Impact Factor: 2.88). 03/2010; 134(3):393-403. DOI: 10.1043/1543-2165-134.3.393
Source: PubMed

ABSTRACT Numerous benign, proliferative, or reactive processes, often related to hormone stimulation or inflammation, occur throughout the female genital tract and may mimic benign or malignant tumors. Several of the more common pseudoneoplastic lesions are discussed in this article, including microglandular hyperplasia of the cervix mimicking well-differentiated endometrial adenocarcinoma, reactive epithelial changes in the fallopian tubes mimicking adenocarcinoma or carcinoma in situ, and pregnancy changes in the ovary including pregnancy luteoma and large solitary luteinized follicular cyst of pregnancy and puerperium that may mimic ovarian neoplasms.
To discuss and illustrate several common lesions of the female genital tract that mimic neoplasms.
Material derived from consultation cases and review of the literature.
Many benign hyperplastic or reactive processes that occur in the female genital tract may be mistaken for neoplasms both clinically and pathologically. Awareness of the features of such lesions will aid in their correct diagnosis and prevent overtreatment of benign processes.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper we consider a number of non-neoplastic and neoplastic lesions of the fallopian tube. Emphasis has been placed on diagnostically difficult entities, some of which result in misdiagnosis and consequent alteration of treatment, including "pseudocarcinomas" that represent a florid epithelial response to acute and/or chronic salpingitis. Endometriosis-related lesions may cause infertility, or undergo malignant transformation to a Mullerian carcinoma, most frequently endometrioid and clear cell types. Pregnancy-related tubal lesions include the easily misdiagnosed metaplastic papillary tumor as well as several manifestations of ectopic pregnancy. Covered briefly are familial conditions such as the Peutz-Jeghers syndrome and its association with tubal mucinous metaplasia, clear cell papillary cystadenoma associated with von Hippel-Lindau syndrome, and the Li Fraumeni syndrome's germline p53 mutation and its association with distal tubal p53 signatures. Miscellaneous tumors discussed include the common adenomatoid tumor and the uncommon female adnexal tumor of probable Wolffian origin. Important issues including the updated staging of fallopian tube carcinomas, and the histopathologic variants of endometrioid carcinomas and their sometimes unusual patterns that engender the potential for confusion with other tumors are briefly noted. The final section covers the relatively recent and novel concept of the fallopian tube as the predominant site of origin of ovarian and peritoneal carcinomas. Discussed are the histologic, immunohistochemical, and molecular biologic evidence that support the tubal fimbria as the site of serous tubal intraepithelial carcinoma, possibly the immediate precursor to high-grade ovarian and peritoneal serous carcinoma.
    International Journal of Gynecological Pathology 06/2014; 33(4). DOI:10.1097/PGP.0000000000000143 · 1.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diese Übersicht fasst pathogenetische und praktische Aspekte der (Sub-)Klassifikation zervikaler glandulärer (Prä-)Neoplasien zusammen und stellt dabei u.a. den Nutzen eines Gradings in Frage. Im Kontext der Differenzialdiagnose gutartiger „Imitate“ wird die phänotypische Variabilität der glandulären Präkanzerosen und Karzinome und deren Unterscheidung mittels Spezialuntersuchungen beschrieben. Hinsichtlich der Karzinome geht es um die Differenzialdiagnose der hochdifferenzierten Neoplasien, darunter das „Minimal-deviation“-Adenokarzinom (MDA, Adenoma malignum), Karzinome mit endometrioider oder villoglandulärer Morphologie sowie die mesonephrischen Hyper- und Neoplasien, ferner um die Kenntnis HPV-negativer glandulärer (Prä-)Neoplasien, darunter die „Gastric-type“-Adenokarzinome und diagnostische Algorithmen zur Unterscheidung primärer und sekundärer zervikaler Adenokarzinome. Schließlich werden die Schwierigkeiten bei der Erkennung frühinvasiver Adenokarzinome kommentiert, speziell auch immanente Fallstricke bei der Bestimmung der Eindringtiefe. This overview summarizes pathogenetic and practical aspects of (sub-)classification of cervical glandular (pre-)neoplasias and, inter alia, calls into question the usefulness of grading. In the context of the differential diagnosis of benign “imitations”, the phenotypic variability of glandular precancerous lesions and carcinomas is described as well as the use of special tests to distinguish them. With regard to carcinomas, the differential diagnosis of well-differentiated neoplasias is addressed including “minimal deviation” adenocarcinoma (MDA, malignant adenoma), carcinomas with endometrioid or villoglandular morphology, and mesonephric hyper- and neoplasias. Furthermore, knowledge of HPV-negative glandular (pre-)neoplasias is covered including “gastric-type” adenocarcinomas and diagnostic algorithms for discriminating between primary and secondary cervical adenocarcinomas. Finally, comments are offered on the difficulties in recognizing early invasive adenocarcinomas, especially also the pitfalls inherent in determining the depth of invasion. SchlüsselwörterZervikale Adenokarzinome–Glanduläre (Prä-)Neoplasie–Terminologie der Vorstadien–HPV-Assoziation–Diagnostik KeywordsCervical adenocarcinomas–Glandular (pre-)neoplasias–Terminology of preliminary stages–HPV association–Diagnostics
    Der Pathologe 11/2011; 32(6):505-513. DOI:10.1007/s00292-011-1481-8 · 0.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Microglandular hyperplasia (MGH) is a benign proliferation of endocervical glands with relatively uniform columnar or cuboidal nuclei, and rare to absent mitoses. Endometrial adenocarcinomas with mucinous differentiation or a microglandular pattern can closely mimic MGH, often resulting in a diagnostic dilemma in small biopsy specimens. Rare unusual morphologic features-mild to moderate nuclear atypia, solid or reticular growth pattern, hobnail and signet ring cells-have been previously reported in MGH. We present 9 cases of unusual, mitotically active-between 5 and 11 mitotic figures per 10 HPF-MGH, all of which presented as endocervical polyps and had morphologic features otherwise typical of MGH. The patients' age ranged between 35 and 56 yr, 2 patients were postmenopausal. High-risk human papillomavirus status was available in 7 patients, all of which were negative. The Ki-67 proliferation index ranged between 1% and 15%, and all cases were negative for p16, carcinoembryonic antigen, and vimentin immunostains. The clinical follow-up ranged from 3 to 76.2 mo, with a median of 40.7 mo, all patients were doing well without evidence of endocervical or endometrial malignancy. In summary, this case series documents the presence of rare cases of MGH demonstrating significant mitotic activity (up to 11/10 HPF) without a negative impact on the clinical prognosis. Mitotic activity alone should be interpreted with caution in small biopsy specimens with microglandular growth pattern. Immunohistochemical stains, especially p16, carcinoembryonic antigen, and vimentin, may be helpful-in addition to the patient's clinical history and human papillomavirus status to rule out endocervical or endometrial malignancy.
    International Journal of Gynecological Pathology 07/2014; 33(5). DOI:10.1097/PGP.0000000000000086 · 1.63 Impact Factor


Available from